Korro Bio holds Analyst Day highlighting KRRO-121 for ammonia control

Korro Bio, Inc.

Hosted virtual Analyst Day on Jan 27, 2026, presenting on KRRO-121 for ammonia control.
KRRO-121 described as a potential first-in-class treatment for ammonia control.
No specific clinical data or milestones disclosed in the filing.

item 8.01 item 9.01

Korro Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-023436

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.